1. Home
  2. MDAIW vs CMCO Comparison

MDAIW vs CMCO Comparison

Compare MDAIW & CMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • CMCO
  • Stock Information
  • Founded
  • MDAIW N/A
  • CMCO 1875
  • Country
  • MDAIW United States
  • CMCO United States
  • Employees
  • MDAIW 78
  • CMCO N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • CMCO Construction/Ag Equipment/Trucks
  • Sector
  • MDAIW Health Care
  • CMCO Industrials
  • Exchange
  • MDAIW Nasdaq
  • CMCO Nasdaq
  • Market Cap
  • MDAIW N/A
  • CMCO N/A
  • IPO Year
  • MDAIW N/A
  • CMCO 1996
  • Fundamental
  • Price
  • MDAIW $0.29
  • CMCO $16.52
  • Analyst Decision
  • MDAIW
  • CMCO Buy
  • Analyst Count
  • MDAIW 0
  • CMCO 2
  • Target Price
  • MDAIW N/A
  • CMCO $44.00
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • CMCO 422.8K
  • Earning Date
  • MDAIW 02-27-2025
  • CMCO 05-28-2025
  • Dividend Yield
  • MDAIW N/A
  • CMCO 1.70%
  • EPS Growth
  • MDAIW N/A
  • CMCO N/A
  • EPS
  • MDAIW N/A
  • CMCO 0.32
  • Revenue
  • MDAIW $27,264,000.00
  • CMCO $981,642,000.00
  • Revenue This Year
  • MDAIW N/A
  • CMCO N/A
  • Revenue Next Year
  • MDAIW N/A
  • CMCO $16.80
  • P/E Ratio
  • MDAIW N/A
  • CMCO $50.89
  • Revenue Growth
  • MDAIW 44.52
  • CMCO N/A
  • 52 Week Low
  • MDAIW $0.08
  • CMCO $11.78
  • 52 Week High
  • MDAIW $0.90
  • CMCO $45.84
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • CMCO 59.59
  • Support Level
  • MDAIW N/A
  • CMCO $14.27
  • Resistance Level
  • MDAIW N/A
  • CMCO $16.04
  • Average True Range (ATR)
  • MDAIW 0.00
  • CMCO 0.73
  • MACD
  • MDAIW 0.00
  • CMCO 0.42
  • Stochastic Oscillator
  • MDAIW 0.00
  • CMCO 95.94

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: